221 related articles for article (PubMed ID: 19551864)
1. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.
Su X; Colditz GA; Willett WC; Collins LC; Schnitt SJ; Connolly JL; Pollak MN; Rosner B; Tamimi RM
Int J Cancer; 2010 Jan; 126(1):180-90. PubMed ID: 19551864
[TBL] [Abstract][Full Text] [Related]
2. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.
Gu F; Schumacher FR; Canzian F; Allen NE; Albanes D; Berg CD; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Buring JE; Chabbert-Buffet N; Chanock SJ; Clavel-Chapelon F; Dumeaux V; Gaziano JM; Giovannucci EL; Haiman CA; Hankinson SE; Hayes RB; Henderson BE; Hunter DJ; Hoover RN; Johansson M; Key TJ; Khaw KT; Kolonel LN; Lagiou P; Lee IM; LeMarchand L; Lund E; Ma J; Onland-Moret NC; Overvad K; Rodriguez L; Sacerdote C; Sánchez MJ; Stampfer MJ; Stattin P; Stram DO; Thomas G; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Virtamo J; Weinstein SJ; Willett WC; Yeager M; Zhang SM; Kaaks R; Riboli E; Ziegler RG; Kraft P
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2877-87. PubMed ID: 20810604
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II.
Rice MS; Tamimi RM; Connolly JL; Collins LC; Shen D; Pollak MN; Rosner B; Hankinson SE; Tworoger SS
Breast Cancer Res; 2012 Mar; 14(2):R44. PubMed ID: 22414675
[TBL] [Abstract][Full Text] [Related]
4. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Rinaldi S; Landi S; Boillot C; Monnier S; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Ardanaz E; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Br J Cancer; 2006 Jan; 94(2):299-307. PubMed ID: 16404426
[TBL] [Abstract][Full Text] [Related]
7. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.
Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L
J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087
[TBL] [Abstract][Full Text] [Related]
8. Genotypes and phenotypes of IGF-I and IGFBP-3 in breast tumors among Chinese women.
Qian B; Zheng H; Yu H; Chen K
Breast Cancer Res Treat; 2011 Nov; 130(1):217-26. PubMed ID: 21562710
[TBL] [Abstract][Full Text] [Related]
9. A comparison of hormonal profiles between breast cancer and benign breast disease: a case-control study.
Lagiou P; Samoli E; Lagiou A; Zourna P; Barbouni A; Georgila C; Tsikkinis A; Vassilarou D; Minaki P; Sfikas C; Spanos E; Trichopoulos D
Ann Oncol; 2013 Oct; 24(10):2527-2533. PubMed ID: 23723293
[TBL] [Abstract][Full Text] [Related]
10. Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.
Tamimi RM; Cox DG; Kraft P; Pollak MN; Haiman CA; Cheng I; Freedman ML; Hankinson SE; Hunter DJ; Colditz GA
Breast Cancer Res; 2007; 9(1):R18. PubMed ID: 17300730
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
12. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density.
Taverne CW; Verheus M; McKay JD; Kaaks R; Canzian F; Grobbee DE; Peeters PH; van Gils CH
Breast Cancer Res Treat; 2010 Oct; 123(3):843-55. PubMed ID: 20155489
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
[TBL] [Abstract][Full Text] [Related]
14. IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.
D'Aloisio AA; Schroeder JC; North KE; Poole C; West SL; Travlos GS; Baird DD
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):954-66. PubMed ID: 19240240
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus.
Siahpush SH; Vaughan TL; Lampe JN; Freeman R; Lewis S; Odze RD; Blount PL; Ayub K; Rabinovitch PS; Reid BJ; Chen C
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2387-95. PubMed ID: 18006928
[TBL] [Abstract][Full Text] [Related]
16. Associations of genetically predicted circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with bladder cancer risk.
Tsai CW; Chang WS; Xu Y; Huang M; Bau DT; Gu J
Mol Carcinog; 2021 Nov; 60(11):726-733. PubMed ID: 34293213
[TBL] [Abstract][Full Text] [Related]
17. Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.
Rinaldi S; Biessy C; Hernandez M; Lesueur F; dos-Santos-Silva I; Rice MS; Lajous M; Lopez-Ridaura R; Torres-Mejía G; Romieu I
Int J Cancer; 2014 Mar; 134(6):1436-44. PubMed ID: 24037648
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review.
Fletcher O; Gibson L; Johnson N; Altmann DR; Holly JM; Ashworth A; Peto J; Silva Idos S
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):2-19. PubMed ID: 15668470
[TBL] [Abstract][Full Text] [Related]
19. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Dossus L; McKay JD; Canzian F; Wilkening S; Rinaldi S; Biessy C; Olsen A; Tjønneland A; Jakobsen MU; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Fournier A; Linseisen J; Lukanova A; Boeing H; Fisher E; Trichopoulou A; Georgila C; Trichopoulos D; Palli D; Krogh V; Tumino R; Vineis P; Quirós JR; Sala N; Martínez-García C; Dorronsoro M; Chirlaque MD; Barricarte A; van Duijnhoven FJ; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Hallmans G; Lenner P; Bingham S; Khaw KT; Key TJ; Travis RC; Ferrari P; Jenab M; Riboli E; Kaaks R
Carcinogenesis; 2008 Jul; 29(7):1360-6. PubMed ID: 18375957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
